[Phillips J, Beam S, Brinker A, Holquist C, Honig P, Lee LY, et al. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001; 58: 1835-41.10.1093/ajhp/58.19.183511596700]Search in Google Scholar
[Ocvirk J, Boc M, Rebersek M, Ros T. Cisplatin-induced non-convulsive posterior reversible encephalopathy syndrome in a 41-year-old woman with metastatic malignant melanoma. Radiol Oncol 2009; 43: 120-5.10.2478/v10019-009-0005-0]Search in Google Scholar
[Department of Health. The NHS cancer plan. London: HMSO; 2001.]Search in Google Scholar
[Goldspiel BR, DeChristoforo R, Daniels CE. A continuous-improvement approach for reducing the number of chemotherapy-related medication errors. Am J Health Syst Pharm 2000; 57: S4-9.10.1093/ajhp/57.suppl_4.S411148943]Search in Google Scholar
[Mort D, Lansdown M, Smith N, Protopapa K, Mason M. For better, for worse? London: National Confidential Enquiry into Patient Outcome and Death; 2008.]Search in Google Scholar
[North East London Cancer Network NHS. Guidelines on the safe prescribing, handling and administration of cytotoxic drugs. London: Department of Health Publications; 2005.]Search in Google Scholar
[German Society of Oncology Pharmacy. Quality Standard for the Oncology Pharmacy Service with Commentary. 4th Edition. Oldenburg: Onko-press; 2003.]Search in Google Scholar
[Adams V, Blake D, Corlett S, Godward D, Low J, McMurray A, et al. Competency Framework for Specialist Oncology Pharmacists. BOPA Newsletter, 2004.]Search in Google Scholar
[Markert A, Thierry V, Kleber M, Behrens M, Engelhardt M. Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment. Int J Cancer 2009; 124: 722-8.10.1002/ijc.2399118989899]Search in Google Scholar
[Jaehde U, Liekwig A, Simons S, Westfeld M. Minimising treatment-associated risks in systemic cancer therapy. Pharm World Sci 2008; 30: 161-8.10.1007/s11096-007-9157-4225365217906939]Search in Google Scholar
[Slama C, Jerome J, Jacquot C, Bonan B. Prescription errors with cytotoxic drugs and inadequacy of existing classifications. Pharm World Sci 2005; 27: 339-43.10.1007/s11096-005-6034-x16228634]Search in Google Scholar
[Liekweg A, Westfeld M, Jaehde U. From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care. Support Care Cancer 2004; 12: 73-9.10.1007/s00520-003-0539-414530957]Search in Google Scholar
[Debevec L, Jerič T, Kovač V, Bitenc M, Sok M: Is there any progress in routine management of lung cancer patients? A comparative analysis of an institution in 1996 and 2006. Radiol Oncol 2009; 43: 47-53.10.2478/v10019-009-0008-x]Search in Google Scholar
[Knez L, Laaksonen R, Duggan C, Nijjar R. Evaluation of clinical interventions made by pharmacists in cancer services. Pharm J 2008; 280: 277-80.]Search in Google Scholar
[Burtonwood AM, Hinchliffe AL, Tinkler GG. A prescription for quality: a role for the clinical pharmacist in general practice. Pharm J 1998; 261: 678-80.]Search in Google Scholar
[Eadon H. Assessing the quality of ward pharmacists' interventions. Int J Pharm Practice 1992; 1: 145-7.10.1111/j.2042-7174.1992.tb00556.x]Search in Google Scholar
[Price RN, Rogers A. Intervention monitoring on admissions wards. Hosp Pharmacists 2000; 7: 81-4.]Search in Google Scholar
[Barber N, Batty R, Ridout DA. Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom. Am J Health Syst Pharm 1997; 54: 397-405.10.1093/ajhp/54.4.3979043562]Search in Google Scholar
[Hawkey CJ, Hodgon S, Norman A, Daneshmend TK, Garner ST. Effect of reactive pharmacy intervention on quality of hospital prescribing. Br Med J 1990; 300: 986-990.10.1136/bmj.300.6730.98616627012344509]Search in Google Scholar
[Allan EL, Barker KN. Fundamentals of medication error research. Am J Hosp Pharm 1990; 47: 555-71.]Search in Google Scholar
[Bowling A. Research methods in health. Philadelphia: Open University Press; 2002.]Search in Google Scholar
[Macintyre J, Dalrymple H, MacLean F, Lannigan N, Hudson S. Development of a system for reporting pharmaceutical care issues in cancer patients receiving chemotherapy. Pharm J 2003; 271: 266-7.]Search in Google Scholar
[Limat S, Drouhin JP, Demesmay K, Tissot E, Jacquet M, Woronoff-Lemsi MC. Incidence and risk factors of preparation errors in centralized cytotoxic preparation unit. Pharm World Sci 2001; 23: 102-6.10.1023/A:1011252132478]Search in Google Scholar
[Bourret JA, Demeres RF, Wordell D, Irani M, Baker J, Evangelista C. Medication use review process and information systems utilized for oncology chemotherapy quality improvement. Pharm Pract Manag Q 1996; 16: 1-17.]Search in Google Scholar
[Barber N, Cornford T, Klecun E. Qualitative evaluation of an electronic prescribing and administration system. Qual Saf Health Care 2007; 16: 271-8.10.1136/qshc.2006.019505246493717693675]Search in Google Scholar
[Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med 2005; 165: 1111-6.10.1001/archinte.165.10.111115911723]Search in Google Scholar